Annual report pursuant to Section 13 and 15(d)

Note 13 - Commitments and Contingencies (Details Textual)

v3.21.1
Note 13 - Commitments and Contingencies (Details Textual)
1 Months Ended 2 Months Ended 12 Months Ended
Mar. 16, 2021
USD ($)
Nov. 27, 2019
USD ($)
Apr. 26, 2019
Aug. 14, 2018
Apr. 09, 2018
USD ($)
Nov. 02, 2017
USD ($)
Mar. 03, 2017
USD ($)
Nov. 30, 2018
shares
Nov. 30, 2017
USD ($)
Jun. 30, 2016
USD ($)
Jan. 31, 2020
shares
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2019
USD ($)
shares
Feb. 14, 2020
USD ($)
Aug. 31, 2018
shares
Stock Issued During Period, Shares, New Issues (in shares) | shares                     2,100,000        
Stockholders' Equity Attributable to Parent, Ending Balance                       $ 1,315,604 $ (1,612,292)    
Market Capitalization, Fair Value                       $ 58,400,000      
Pro Forma [Member]                              
Stockholders' Equity Attributable to Parent, Ending Balance                           $ 6,000,000  
Common Stock [Member]                              
Stock Issued During Period, Shares, New Issues (in shares) | shares                       1,647,059 8,000,000    
Former Chief Executive Officer and President [Member]                              
Common Stock Shares Provided by Agreement (in shares) | shares                             1,175,000
Common Stock Shares Provided by Agreement, Escrow Period (Month)       1 year 180 days                      
Former Chief Executive Officer and President [Member] | Common Stock [Member]                              
Stock Issued During Period, Shares, New Issues (in shares) | shares               925,000              
Stock Issued During Period, Shares, New Issues Placed in Escrow (in shares) | shares               250,000       250,000      
Former Chief Executive Officer and President [Member] | MT [Member] | Common Stock [Member] | Dr. Michael Goldberg [Member]                              
Ownership Percentage       5.00%                      
CRG [Member]                              
Draws on Letter of Credit         $ 7,100,000                    
CRG Loan Agreement, Texas Case [Member] | Judicial Ruling [Member]                              
Loss Contingency, Damages Awarded, Value, Additional Amount             $ 7,000,000                
Loss Contingency, Damages Awarded, Value, Amount not Taken into Consideration                   $ 4,100,000          
Ohio Court of Common Pleas [Member]                              
Litigation Settlement, Amount Awarded from Other Party   $ 4,300,000                          
Ohio Court of Common Pleas [Member] | Subsequent Event [Member]                              
Litigation Settlement, Reversal of Amount Awarded from Other Party $ 4,300,000                            
Platinum-Montaur Life Sciences LLC Litigation [Member]                              
Loss Contingency, Damages Sought, Value                 $ 1,900,000            
Platinum-Montaur Life Sciences LLC Litigation [Member] | Pending Litigation [Member]                              
Loss Contingency, Damages Sought, Value           $ 1,900,000                  
Maximum [Member] | Before Reverse Stock Split [Member]                              
Stockholders' Equity Note, Stock Split, Conversion Ratio     20                        
CRG [Member] | Term Loan Agreement [Member] | CRG Loan Agreement, Texas Case [Member] | Judicial Ruling [Member]                              
Repayments of Debt             59,000,000                
CRG [Member] | Term Loan Agreement [Member] | Maximum [Member]                              
Debt Instrument, Agreed-upon Final Payoff Amount             $ 66,000,000